Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 44
- Incorporated in 2018
- HQ: Encinitas, California
- https://ventyxbio.com
Ventyx Biosciences priced upsized 9,472,656 share IPO at $16/share, at the midpoint of the $15-17 expected range
Opened at $18.65
No comments:
Post a Comment